Ashton Thomas Securities LLC Makes New Investment in BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Ashton Thomas Securities LLC purchased a new stake in BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) during the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 9,500 shares of the company’s stock, valued at approximately $156,000.

Other institutional investors also recently made changes to their positions in the company. Truist Financial Corp acquired a new position in BlackRock Capital Allocation Term Trust during the second quarter valued at approximately $319,000. Ironsides Asset Advisors LLC raised its stake in shares of BlackRock Capital Allocation Term Trust by 14.1% in the 1st quarter. Ironsides Asset Advisors LLC now owns 29,133 shares of the company’s stock valued at $485,000 after acquiring an additional 3,606 shares during the period. Oppenheimer & Co. Inc. raised its stake in shares of BlackRock Capital Allocation Term Trust by 18.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 29,180 shares of the company’s stock valued at $486,000 after acquiring an additional 4,586 shares during the period. Claro Advisors LLC lifted its holdings in shares of BlackRock Capital Allocation Term Trust by 101.3% during the 3rd quarter. Claro Advisors LLC now owns 31,734 shares of the company’s stock valued at $522,000 after acquiring an additional 15,969 shares in the last quarter. Finally, Almitas Capital LLC purchased a new stake in BlackRock Capital Allocation Term Trust during the 2nd quarter worth $728,000. 36.12% of the stock is owned by hedge funds and other institutional investors.

BlackRock Capital Allocation Term Trust Price Performance

NYSE:BCAT opened at $16.29 on Wednesday. The business’s 50-day moving average is $16.30 and its two-hundred day moving average is $16.30. BlackRock Capital Allocation Term Trust has a 12 month low of $14.53 and a 12 month high of $17.18.

BlackRock Capital Allocation Term Trust Increases Dividend

The business also recently announced a monthly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be issued a dividend of $0.2885 per share. This is an increase from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. This represents a $3.46 annualized dividend and a dividend yield of 21.26%. The ex-dividend date is Friday, November 15th.

Insider Buying and Selling

In other BlackRock Capital Allocation Term Trust news, major shareholder Saba Capital Management, L.P. sold 28,670 shares of the stock in a transaction that occurred on Monday, October 21st. The shares were sold at an average price of $16.27, for a total value of $466,460.90. Following the completion of the sale, the insider now owns 14,888,870 shares of the company’s stock, valued at $242,241,914.90. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In the last ninety days, insiders have sold 723,927 shares of company stock valued at $11,925,047.

BlackRock Capital Allocation Term Trust Company Profile

(Free Report)

Further Reading

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.